{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:09:16Z","timestamp":1778638156174,"version":"3.51.4"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004612","name":"Funda\u00e7\u00e3o Arauc\u00e1ria","doi-asserted-by":"publisher","award":["SUS2020131000003"],"award-info":[{"award-number":["SUS2020131000003"]}],"id":[{"id":"10.13039\/501100004612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004612","name":"Funda\u00e7\u00e3o Arauc\u00e1ria","doi-asserted-by":"publisher","award":["2020\/2021"],"award-info":[{"award-number":["2020\/2021"]}],"id":[{"id":"10.13039\/501100004612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["404286 \/2021-6"],"award-info":[{"award-number":["404286 \/2021-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["304699 \/2025-0"],"award-info":[{"award-number":["304699 \/2025-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["CNPq404286\/2021-6"],"award-info":[{"award-number":["CNPq404286\/2021-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["TTU 08.716"],"award-info":[{"award-number":["TTU 08.716"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["TTU06.716"],"award-info":[{"award-number":["TTU06.716"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.abb.2026.110761","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T17:07:52Z","timestamp":1770656872000},"page":"110761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Identification of an N-methylpyrazole derivative as a selective inhibitor of breast cancer resistance protein (BCRP\/ABCG2)"],"prefix":"10.1016","volume":"779","author":[{"given":"Andrezza Braiane Ferreira","family":"Sirid\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur Henrique","family":"Gomes de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Poletto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thales","family":"Kronenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiane Gomes de Moraes","family":"Rego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geraldo","family":"Picheth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Le Borgne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahc\u00e8ne","family":"Boumendjel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Andreia","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1882-1512","authenticated-orcid":false,"given":"Glaucio","family":"Valdameri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian Rotuno","family":"Moure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.abb.2026.110761_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szak\u00e1cs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.abb.2026.110761_bib2","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.abb.2026.110761_bib3","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.3390\/molecules28145359","article-title":"The importance of the pyrazole scaffold in the design of protein kinases inhibitors as targeted anticancer therapies","volume":"28","author":"Nitulescu","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.abb.2026.110761_bib4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.abb.2026.110761_bib5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.biochem.71.102301.093055","article-title":"Mammalian ABC transporters in health and disease","volume":"71","author":"Borst","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.abb.2026.110761_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev-biophys-111622-091232","article-title":"Structure and mechanism of human ABC transporters","volume":"52","author":"Alam","year":"2023","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.abb.2026.110761_bib7","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41568-023-00612-3","article-title":"Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters","volume":"23","author":"Sajid","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.abb.2026.110761_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.abb.2026.110761_bib9","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1360704","article-title":"Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line","volume":"258","author":"Cole","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.abb.2026.110761_bib10","first-page":"15665","article-title":"A multidrug resistance transporter from human MCF-7 breast cancer cells (mitoxantrone\u035eanthracyclines\u035etransporter proteins)","volume":"95","author":"Doyle","year":"1998","journal-title":"Med. Sci."},{"key":"10.1016\/j.abb.2026.110761_bib11","first-page":"8","article-title":"Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes","volume":"59","author":"Miyake","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.abb.2026.110761_bib12","first-page":"5337","article-title":"A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance","volume":"58","author":"Allikmets","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.abb.2026.110761_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114346","article-title":"Targeting breast cancer resistance protein (BCRP\/ABCG2): functional inhibitors and expression modulators","volume":"237","author":"Zattoni","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.abb.2026.110761_bib14","doi-asserted-by":"crossref","DOI":"10.4155\/fdd-2020-0025","article-title":"Vesicular ATP-binding cassette transporters in human disease: relevant aspects of their organization for future drug development","volume":"2","author":"Stefan","year":"2020","journal-title":"Future Drug Discovery"},{"key":"10.1016\/j.abb.2026.110761_bib15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bcp.2017.11.018","article-title":"ATP-binding cassette transporter-2 (ABCA2) as a therapeutic target","volume":"151","author":"Davis","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.abb.2026.110761_bib16","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.4155\/fmc-2019-0185","article-title":"Multi-target ABC transporter modulators: what next and where to go?","volume":"11","author":"Stefan","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.abb.2026.110761_bib17","first-page":"585","article-title":"Reversal of a novel multidrug resistance mechanism in human Colon carcinoma cells by fumitremorgin C","volume":"58","author":"Rabindran","year":"1998","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.abb.2026.110761_bib18","first-page":"417","article-title":"Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C","volume":"1","author":"Allen","year":"2002","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.abb.2026.110761_bib19","doi-asserted-by":"crossref","first-page":"6782","DOI":"10.1021\/acs.jmedchem.3c00168","article-title":"In vitro and in vivo evaluation of ABCG2 (BCRP) inhibitors derived from Ko143","volume":"66","author":"Zechner","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.abb.2026.110761_bib20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1124\/jpet.115.225482","article-title":"The inhibitor Ko143 is not specific for ABCG2","volume":"354","author":"Weidner","year":"2015","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.abb.2026.110761_bib21","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/s41598-020-79892-w","article-title":"Mechanistic basis of breast cancer resistance protein inhibition by new indeno[1,2-b]indoles","volume":"11","author":"Kita","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.abb.2026.110761_bib22","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3390\/pharmaceutics15041259","article-title":"Characterization of potent ABCG2 inhibitor derived from chromone: from the mechanism of inhibition to human extracellular vesicles for drug delivery","volume":"15","author":"Valdameri","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.abb.2026.110761_bib23","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41597-022-01506-z","article-title":"A curated binary pattern multitarget dataset of focused ATP-binding cassette transporter inhibitors","volume":"9","author":"Stefan","year":"2022","journal-title":"Sci. Data"},{"key":"10.1016\/j.abb.2026.110761_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1235285","article-title":"The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells","volume":"14","author":"Gao","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.abb.2026.110761_bib25","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1158\/1535-7163.MCT-16-0589","article-title":"Discovery and pharmacological characterization of JNJ-42756493 (Erdafitinib), a functionally selective small-molecule FGFR family inhibitor","volume":"16","author":"Perera","year":"2017","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.abb.2026.110761_bib26","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3389\/fonc.2020.00955","article-title":"Erdafitinib antagonizes ABCB1-Mediated multidrug resistance in cancer cells","volume":"10","author":"Feng","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.abb.2026.110761_bib27","doi-asserted-by":"crossref","first-page":"10645","DOI":"10.1021\/acs.jmedchem.9b00966","article-title":"Optimizing targeted inhibitors of P-Glycoprotein using computational and structure-guided approaches","volume":"62","author":"Wise","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.abb.2026.110761_bib28","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1016\/j.csbj.2021.05.018","article-title":"Scaffold fragmentation and substructure hopping reveal potential, robustness, and limits of computer-aided pattern analysis (C@PA)","volume":"19","author":"Namasivayam","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.abb.2026.110761_bib29","doi-asserted-by":"crossref","unstructured":"Small-Molecule Multidrug Resistance\u2013Associated Protein 1 Inhibitor Reversan Increases the Therapeutic Index of Chemotherapy in Mouse Models of Neuroblastoma | Cancer Research | American Association for Cancer Research, (n.d.). https:\/\/aacrjournals.org\/cancerres\/article\/69\/16\/6573\/549936\/Small-Molecule-Multidrug-Resistance-Associated (accessed October 20, 2025).","DOI":"10.1158\/0008-5472.CAN-09-1075"},{"key":"10.1016\/j.abb.2026.110761_bib30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3390\/cells9030613","article-title":"The Pyrazolo[3,4-d]pyrimidine derivative, SCO-201, reverses multidrug resistance mediated by ABCG2\/BCRP","volume":"9","author":"Ambj\u00f8rner","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.abb.2026.110761_bib31","doi-asserted-by":"crossref","first-page":"8544","DOI":"10.1021\/acs.joc.2c00657","article-title":"Regiodivergent synthesis of 3,4- and 4,5-Disubstituted N-Methylpyrazoles from 4-Acyl-1H-pyrrole-2,3-dione and methylhydrazine","volume":"87","author":"Poletto","year":"2022","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.abb.2026.110761_bib32","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.bjc.6601370","article-title":"Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity","volume":"89","author":"Robey","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.abb.2026.110761_bib33","doi-asserted-by":"crossref","first-page":"25153","DOI":"10.1016\/S0021-9258(19)74018-6","article-title":"Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters","volume":"267","author":"Currier","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2026.110761_bib34","doi-asserted-by":"crossref","first-page":"30962","DOI":"10.1074\/jbc.272.49.30962","article-title":"ATPase activity of purified multidrug resistance-associated protein","volume":"272","author":"Chang","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2026.110761_bib35","first-page":"6011","article-title":"Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium","volume":"46","author":"Gazdar","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.abb.2026.110761_bib36","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1158\/0008-5472.CAN-03-3298","article-title":"Pheophorbide a is a specific probe for ABCG2 function and inhibition","volume":"64","author":"Robey","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.abb.2026.110761_bib37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejmech.2016.05.053","article-title":"New, highly potent and non-toxic, chromone inhibitors of the human breast cancer resistance protein ABCG2","volume":"122","author":"Pires","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.abb.2026.110761_bib38","first-page":"3681","article-title":"Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity","volume":"50","author":"Heo","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.abb.2026.110761_bib39","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK(a) prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.abb.2026.110761_bib40","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.abb.2026.110761_bib41","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.abb.2026.110761_bib42","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.abb.2026.110761_bib43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prot.10613","article-title":"A hierarchical approach to all-atom protein loop prediction","volume":"55","author":"Jacobson","year":"2004","journal-title":"Proteins"},{"key":"10.1016\/j.abb.2026.110761_bib44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3835(99)00182-2","article-title":"Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR","volume":"146","author":"de Bruin","year":"1999","journal-title":"Cancer Lett."},{"key":"10.1016\/j.abb.2026.110761_bib45","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1021\/acs.jmedchem.0c02199","article-title":"C@PA: computer-aided pattern analysis to predict multitarget ABC transporter inhibitors","volume":"64","author":"Namasivayam","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.abb.2026.110761_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117049","article-title":"Polypharmacology translates between species and phylogenetic distance: a functional, bioinformatic, and structural study on organic anion transporting polypeptides","volume":"239","author":"Stefan","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.abb.2026.110761_bib47","article-title":"Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy-coupling factor transporters (ECFTs)","volume":"357","author":"Haupenthal","year":"2024","journal-title":"Arch. Pharm. (Weinh.)"},{"key":"10.1016\/j.abb.2026.110761_bib48","first-page":"1155","article-title":"Structural and molecular characterization of lopinavir and ivermectin as breast cancer resistance protein (BCRP\/ABCG2) inhibitors","volume":"22","author":"Dutra","year":"2023","journal-title":"EXCLI Journal"},{"key":"10.1016\/j.abb.2026.110761_bib49","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1158\/1535-7163.MCT-06-0087","article-title":"Modulation of the function of the multidrug resistance\u2013linked ATP-binding cassette transporter ABCG2 by the cancer chemopreventive agent curcumin","volume":"5","author":"Chearwae","year":"2006","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.abb.2026.110761_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109718","article-title":"A new porphyrin as selective substrate-based inhibitor of breast cancer resistance protein (BCRP\/ABCG2)","volume":"351","author":"Zattoni","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.abb.2026.110761_bib51","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1021\/jm201404w","article-title":"Substituted chromones as highly potent nontoxic inhibitors, specific for the breast cancer resistance protein","volume":"55","author":"Valdameri","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.abb.2026.110761_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111772","article-title":"Optimization of the chromone scaffold through QSAR and docking studies: identification of potent inhibitors of ABCG2","volume":"184","author":"Roussel","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.abb.2026.110761_bib53","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/bdd.699","article-title":"Interaction of angiotensin receptor type 1 blockers with ATP\u2010binding cassette transporters","volume":"31","author":"Weiss","year":"2010","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.abb.2026.110761_bib54","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s11095-005-8384-4","article-title":"BCRP transports dipyridamole and is inhibited by calcium channel blockers","volume":"22","author":"Zhang","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.abb.2026.110761_bib55","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1158\/0008-5472.CAN-04-1817","article-title":"Flavonoid structure-activity studies identify 6-Prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2","volume":"65","author":"Ahmed-Belkacem","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.abb.2026.110761_bib56","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00280-005-0173-6","article-title":"Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan","volume":"58","author":"Gupta","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.abb.2026.110761_bib57","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1021\/cb200435y","article-title":"Methoxy stilbenes as potent, specific, untransported, and noncytotoxic inhibitors of breast cancer resistance protein","volume":"7","author":"Valdameri","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.abb.2026.110761_bib58","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/cmdc.201200154","article-title":"6-Halogenochromones bearing tryptamine: one-step access to potent and highly selective inhibitors of breast cancer resistance protein","volume":"7","author":"Valdameri","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.abb.2026.110761_bib59","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1021\/jm2016528","article-title":"Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity","volume":"55","author":"Valdameri","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.abb.2026.110761_bib60","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1021\/jm8013822","article-title":"Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar","volume":"52","author":"K\u00fchnle","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.abb.2026.110761_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107283","article-title":"Magnolol derivatives as specific and noncytotoxic inhibitors of breast cancer resistance protein (BCRP\/ABCG2)","volume":"146","author":"Da Silva Zanzarini","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.abb.2026.110761_bib62","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1074\/jbc.M411338200","article-title":"Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface","volume":"280","author":"\u00d6zvegy-Laczka","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2026.110761_bib63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejps.2011.10.021","article-title":"Antibody binding shift assay for rapid screening of drug interactions with the human ABCG2 multidrug transporter","volume":"45","author":"Telbisz","year":"2012","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.abb.2026.110761_bib64","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1021\/acschembio.4c00353","article-title":"Modulation of ABCG2 transporter activity by Ko143 derivatives","volume":"19","author":"Yu","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.abb.2026.110761_bib65","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/biom14020231","article-title":"Structural view of cryo-electron microscopy-determined ATP-binding cassette transporters in human multidrug resistance","volume":"14","author":"Fan","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.abb.2026.110761_bib66","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1038\/s41467-019-13302-2","article-title":"The ABCG2 multidrug transporter is a pump gated by a valve and an extracellular lid","volume":"10","author":"Khunweeraphong","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.abb.2026.110761_bib67","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41594-018-0049-1","article-title":"Structural basis of small-molecule inhibition of human multidrug transporter ABCG2","volume":"25","author":"Jackson","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.abb.2026.110761_bib68","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1038\/s41467-020-16155-2","article-title":"ABCG2 transports anticancer drugs via a closed-to-open switch","volume":"11","author":"Orlando","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.abb.2026.110761_bib69","doi-asserted-by":"crossref","first-page":"13386","DOI":"10.1073\/pnas.1309275110","article-title":"Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain","volume":"110","author":"Ward","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.abb.2026.110761_bib70","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/febs.12613","article-title":"Understanding polyspecificity within the substrate-binding cavity of the human multidrug resistance P-glycoprotein","volume":"281","author":"Martinez","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.abb.2026.110761_bib71","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.cell.2017.01.041","article-title":"Structural basis of substrate recognition by the multidrug resistance protein MRP1","volume":"168","author":"Johnson","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.abb.2026.110761_bib72","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3390\/membranes13060568","article-title":"The alternating access mechanism in Mammalian multidrug resistance transporters and their bacterial homologs","volume":"13","author":"Badiee","year":"2023","journal-title":"Membranes"}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986126000329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986126000329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:15:34Z","timestamp":1778634934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986126000329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":72,"alternative-id":["S0003986126000329"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2026.110761","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of an N-methylpyrazole derivative as a selective inhibitor of breast cancer resistance protein (BCRP\/ABCG2)","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2026.110761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110761"}}